TP63 Gene Complete Identifier and Functional Mapping Reference
Provide a comprehensive cross-database identifier and functional mapping reference for human TP63. This should serve as a definitive lookup resource …
Provide a comprehensive cross-database identifier and functional mapping reference for human TP63. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section
Structured Data Sources
This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 31 biological databases.
Further analyze this answer or run your own queries with BioBTree MCP.
alphafold, alphamissense, bgee, ccds, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, jaspar, mim, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, scxa, spliceai, string_interaction, transcript, uniprotView API calls (43)
- search(TP63) https://sugi.bio/biobtree/api/search?i=TP63
- search(TP63, hgnc) https://sugi.bio/biobtree/api/search?i=TP63&s=hgnc
- entry(HGNC:15979, hgnc) https://sugi.bio/biobtree/api/entry?i=HGNC%3A15979&s=hgnc
- entry(ENSG00000073282, ensembl) https://sugi.bio/biobtree/api/entry?i=ENSG00000073282&s=ensembl
- entry(8626, entrez) https://sugi.bio/biobtree/api/entry?i=8626&s=entrez
- map(ENSG00000073282, >>ensembl>>transcript) https://sugi.bio/biobtree/api/map?i=ENSG00000073282&m=%3E%3Eensembl%3E%3Etranscript
- map(ENSG00000073282, >>ensembl>>uniprot) https://sugi.bio/biobtree/api/map?i=ENSG00000073282&m=%3E%3Eensembl%3E%3Euniprot
- map(HGNC:15979, >>hgnc>>mim) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Emim
- map(HGNC:15979, >>hgnc>>refseq) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Erefseq
- entry(Q9H3D4, uniprot) https://sugi.bio/biobtree/api/entry?i=Q9H3D4&s=uniprot
- map(HGNC:15979, >>hgnc>>ccds) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eccds
- map(ENSG00000073282, >>ensembl>>ortholog) https://sugi.bio/biobtree/api/map?i=ENSG00000073282&m=%3E%3Eensembl%3E%3Eortholog
- map(Q9H3D4, >>uniprot>>interpro) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Einterpro
- map(Q9H3D4, >>uniprot>>pdb) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Epdb
- map(Q9H3D4, >>uniprot>>alphafold) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ealphafold
- map(Q9H3D4, >>uniprot>>go) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ego
- map(HGNC:15979, >>hgnc>>clinvar) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eclinvar
- map(HGNC:15979, >>hgnc>>spliceai) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Espliceai
- map(Q9H3D4, >>uniprot>>alphamissense) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ealphamissense
- map(HGNC:15979, >>hgnc>>clinvar[germline_classification=="Pathogenic"]) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eclinvar%5Bgermline_classification%3D%3D%22Pathogenic%22%5D
- map(Q9H3D4, >>uniprot>>reactome) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ereactome
- map(Q9H3D4, >>uniprot>>string_interaction) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Estring_interaction
- map(Q9H3D4, >>uniprot>>intact) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Eintact
- map(HGNC:15979, >>hgnc>>hpo) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Ehpo
- map(HGNC:15979, >>hgnc>>gencc) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Egencc
- map(HGNC:15979, >>hgnc>>orphanet) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eorphanet
- map(HGNC:15979, >>hgnc>>gwas) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Egwas
- map(HGNC:15979, >>hgnc>>collectri) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Ecollectri
- map(Q9H3D4, >>uniprot>>jaspar) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ejaspar
- map(Q9H3D4, >>uniprot>>esm2_similarity) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Eesm2_similarity
- map(Q9H3D4, >>uniprot>>diamond_similarity) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ediamond_similarity
- map(ENSG00000073282, >>ensembl>>bgee) https://sugi.bio/biobtree/api/map?i=ENSG00000073282&m=%3E%3Eensembl%3E%3Ebgee
- entry(ENST00000264731, transcript) https://sugi.bio/biobtree/api/entry?i=ENST00000264731&s=transcript
- map(ENST00000264731, >>transcript>>exon) https://sugi.bio/biobtree/api/map?i=ENST00000264731&m=%3E%3Etranscript%3E%3Eexon
- entry(ENSG00000073282, bgee) https://sugi.bio/biobtree/api/entry?i=ENSG00000073282&s=bgee
- map(ENSG00000073282, >>ensembl>>scxa) https://sugi.bio/biobtree/api/map?i=ENSG00000073282&m=%3E%3Eensembl%3E%3Escxa
- entry(PA162406776, pharmgkb_gene) https://sugi.bio/biobtree/api/entry?i=PA162406776&s=pharmgkb_gene
- map(HGNC:15979, >>hgnc>>clinvar[germline_classification=="Likely pathogenic"]) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eclinvar%5Bgermline_classification%3D%3D%22Likely%20pathogenic%22%5D
- map(Q9H3D4, >>uniprot>>alphamissense[am_class=="likely_pathogenic"]) https://sugi.bio/biobtree/api/map?i=Q9H3D4&m=%3E%3Euniprot%3E%3Ealphamissense%5Bam_class%3D%3D%22likely_pathogenic%22%5D
- map(HGNC:15979, >>hgnc>>spliceai[score>=0.8]) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Espliceai%5Bscore%3E%3D0.8%5D
- entry(NM_003722, refseq) https://sugi.bio/biobtree/api/entry?i=NM_003722&s=refseq
- entry(603273, mim) https://sugi.bio/biobtree/api/entry?i=603273&s=mim
- map(HGNC:15979, >>hgnc>>clinvar) https://sugi.bio/biobtree/api/map?i=HGNC%3A15979&m=%3E%3Ehgnc%3E%3Eclinvar
TP63 - COMPREHENSIVE CROSS-DATABASE IDENTIFIER AND FUNCTIONAL MAPPING REFERENCE ╔══════════════════════════════════════════════════════════════════════════════╗ ║ TUMOR PROTEIN P63 (TP63) - HUMAN ║ ║ Complete Identifier Reference ║ ╚══════════════════════════════════════════════════════════════════════════════╝
Section 1: Gene Identifiers Primary Gene Identifiers
| Database | Identifier | Notes |
|---|---|---|
| HGNC | HGNC:15979 | Approved symbol: TP63 |
| Ensembl | ENSG00000073282 | GRCh38 |
| NCBI Entrez | 8626 | |
| OMIM | 603273 | Gene/locus entry |
| Attribute | Value |
|---|---|
| Chromosome | 3 |
| Cytogenetic band | 3q28 |
| Start position | 189,631,389 |
| End position | 189,897,276 |
| Strand | + (plus/forward) |
| Genomic accession | NC_000003.12 |
| Gene span | 265,888 bp |
- Locus type: gene with protein product
- Locus group: protein-coding gene
- Gene groups: MicroRNA protein coding host genes
Section 2: Transcript Identifiers Ensembl Transcripts Total transcript count: 14
| Transcript ID | Biotype | Start | End | UTR5 | UTR3 |
|---|---|---|---|---|---|
| ENST00000264731 | protein_coding | 189631389 | 189897276 | 189631389-189631515 | 189894503-189897276 |
| ENST00000320472 | protein_coding | 189631488 | 189894702 | 189631488-189631515 | 189894232-189894702 |
| ENST00000354600 | protein_coding | 189789659 | 189897276 | 189789659-189789800 | 189894503-189897276 |
| ENST00000392460 | protein_coding | 189631516 | 189894221 | - | - |
| ENST00000392461 | protein_coding | 189789801 | 189894231 | - | - |
| ENST00000392463 | protein_coding | 189789801 | 189894221 | - | - |
| ENST00000418709 | protein_coding | 189631488 | 189881496 | 189631488-189631515 | 189880179-189881496 |
| ENST00000434928 | protein_coding | 189789675 | 189864268 | 189789675-189789800 | - |
| ENST00000437221 | protein_coding | 189789801 | 189881496 | - | 189880179-189881496 |
| ENST00000440651 | protein_coding | 189631516 | 189894502 | - | - |
| ENST00000449992 | protein_coding | 189789801 | 189894502 | - | - |
| ENST00000456148 | protein_coding | 189789801 | 189894502 | - | - |
| ENST00000460036 | retained_intron | 189789695 | 189873575 | - | - |
| ENST00000486398 | retained_intron | 189631416 | 189738896 | - | - |
| Accession | Type | MANE Select | Notes |
|---|---|---|---|
| NM_003722.5 | mRNA | YES | Canonical clinical standard |
| NM_001114978 | mRNA | No | |
| NM_001114979 | mRNA | No | |
| NM_001114980 | mRNA | No | |
| NM_001114981 | mRNA | No | |
| NM_001114982 | mRNA | No | |
| NM_001329144 | mRNA | No | |
| NM_001329145 | mRNA | No | |
| NM_001329146 | mRNA | No | |
| NM_001329148 | mRNA | No | |
| NM_001329149 | mRNA | No | |
| NM_001329150 | mRNA | No | |
| NM_001329964 | mRNA | No |
| CCDS ID |
|---|
| CCDS3293 (canonical) |
| CCDS46976 |
| CCDS46977 |
| CCDS46978 |
| CCDS46979 |
| CCDS46980 |
| CCDS82887 |
| CCDS87179 |
| CCDS87180 |
| CCDS87181 |
| Exon ID | Start | End | Length |
|---|---|---|---|
| ENSE00001343828 | 189631389 | 189631577 | 189 bp |
| ENSE00003502961 | 189737740 | 189737868 | 129 bp |
| ENSE00001184832 | 189738642 | 189738774 | 133 bp |
| ENSE00003473100 | 189808272 | 189808526 | 255 bp |
| ENSE00003597426 | 189864232 | 189864418 | 187 bp |
| ENSE00003476123 | 189866682 | 189866797 | 116 bp |
| ENSE00003641501 | 189867833 | 189867942 | 110 bp |
| ENSE00003525444 | 189868580 | 189868716 | 137 bp |
| ENSE00003672778 | 189869324 | 189869406 | 83 bp |
| ENSE00000871463 | 189872859 | 189872995 | 137 bp |
| ENSE00001005407 | 189886394 | 189886551 | 158 bp |
| ENSE00000781605 | 189889340 | 189889484 | 145 bp |
| ENSE00000781606 | 189890789 | 189890882 | 94 bp |
| ENSE00001608550 | 189894206 | 189897276 | 3071 bp |
Section 3: Protein Identifiers UniProt Accessions Total: 5 entries
| Accession | Status | Notes |
|---|---|---|
| Q9H3D4 | Reviewed (Swiss-Prot) | Canonical entry |
| A0A0S2Z4N5 | Unreviewed (TrEMBL) | Isoform |
| A0A0S2Z4N6 | Unreviewed (TrEMBL) | Isoform |
| C9D7D0 | Unreviewed (TrEMBL) | Isoform |
| C9JW72 | Unreviewed (TrEMBL) | Isoform |
| Property | Value |
|---|---|
| Name | Tumor protein 63 |
| Alternative names | Chronic ulcerative stomatitis protein, Keratinocyte transcription factor KET, Transformation-related protein 63, Tumor protein p73-like, p40, p51 |
| Length | 680 amino acids |
| Mass | 76,785 Da |
| Accession | MANE Select |
|---|---|
| NP_003713.3 | YES |
| NP_001108450 | No |
| NP_001108451 | No |
| NP_001108452 | No |
| NP_001108453 | No |
| NP_001108454 | No |
| NP_001316073 | No |
| NP_001316074 | No |
| NP_001316075 | No |
| NP_001316077 | No |
| NP_001316078 | No |
| NP_001316079 | No |
| NP_001316893 | No |
| InterPro ID | Name | Type |
|---|---|---|
| IPR002117 | p53_tumour_suppressor | Family |
| IPR011615 | p53_DNA-bd | Domain |
| IPR010991 | p53_tetrameristn | Domain |
| IPR001660 | SAM | Domain |
| IPR037611 | Tumor-p63_SAM | Domain |
| IPR057064 | P53_central_site | Conserved_site |
| IPR008967 | p53-like_TF_DNA-bd_sf | Homologous_superfamily |
| IPR012346 | p53/RUNT-type_TF_DNA-bd_sf | Homologous_superfamily |
| IPR013761 | SAM/pointed_sf | Homologous_superfamily |
| IPR036674 | p53_tetramer_sf | Homologous_superfamily |
Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB structure count: 25
| PDB ID | Method | Resolution | Title |
|---|---|---|---|
| 1RG6 | NMR | - | Solution structure of the C-terminal domain of p63 |
| 2NB1 | NMR | - | P63/p73 hetero-tetramerisation domain |
| 2RMN | NMR | - | Solution structure of the p63 DNA-binding domain |
| 2Y9T | NMR | - | p63a SAM domain mutants (AEC syndrome) |
| 2Y9U | X-ray | 1.60 Å | p63a SAM domain mutants (AEC syndrome) |
| 3QYM | X-ray | 3.20 Å | p63 DBD with 10bp A/T rich response element |
| 3QYN | X-ray | 2.50 Å | p63 DBD with 22bp response element (2bp spacer) |
| 3US0 | X-ray | 2.50 Å | p63 DBD with response element (AT spacer) |
| 3US1 | X-ray | 2.80 Å | p63 DBD with response element (GC spacer) |
| 3US2 | X-ray | 4.20 Å | p63 DBD with 19bp response element |
| 3ZY0 | X-ray | 1.90 Å | p63 tetramerization domain (truncated) |
| 3ZY1 | X-ray | 2.15 Å | p63 tetramerization domain |
| 4A9Z | X-ray | 2.29 Å | p63 tetramerization domain |
| 6FGN | NMR | - | p300Taz2-p63TA solution structure |
| 6RU6 | X-ray | 2.05 Å | CK1d with p63 PAD1P peptide |
| 6RU7 | X-ray | 2.08 Å | CK1d with p63 PAD2P peptide |
| 6RU8 | X-ray | 1.92 Å | CK1d with p63 PAD3P peptide |
| 7Z71 | X-ray | 1.85 Å | p63 DBD with darpin C14 |
| 7Z72 | X-ray | 1.80 Å | p63 SAM with darpin A5 |
| 7Z73 | X-ray | 2.27 Å | p63 tetramerization with darpin 8F1 |
| 7Z7E | X-ray | 1.80 Å | p63 DBD with inhibitory DARPin G4 |
| 8P9C | X-ray | 1.76 Å | p63-p73 heterotetramer with darpin |
| 8P9D | X-ray | 2.70 Å | p63-p73 heterotetramer with darpin |
| 8P9E | X-ray | 2.25 Å | p63-p73 heterotetramer (WT) with darpin |
| 9GFO | X-ray | 2.40 Å | iASPP-CTD fusion to p63 peptide |
| Property | Value |
|---|---|
| AlphaFold ID | Q9H3D4 |
| Global pLDDT | 63.70 |
| Sequence length | 5382 |
| Fraction very high confidence | 0.35 (35%) |
Section 5: Cross-Species Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|---|---|---|
| Mouse (Mus musculus) | ENSMUSG00000022510 | Trp63 | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000001924 | Tp63 | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000044356 | tp63 | protein_coding |
| Fruit fly (Drosophila melanogaster) | FBGN0039044 | p53 | protein_coding |
| Worm (C. elegans) | No ortholog data available | - | - |
| Yeast (S. cerevisiae) | No ortholog data available | - | - |
Section 6: Clinical Variants & AI Predictions Clinical Variant Summary (ClinVar) Total variant count: 827
| Classification | Count |
|---|---|
| Pathogenic | 66 |
| Likely pathogenic | 50 |
| Pathogenic/Likely pathogenic | ~10 |
| Uncertain significance (VUS) | ~150 |
| Likely benign | ~200 |
| Benign | ~300 |
| Conflicting | ~10 |
| Variant ID | HGVS | Type | Classification |
|---|---|---|---|
| 6527 | c.727C>T (p.Arg243Trp) | SNV | Pathogenic |
| 6532 | c.955C>T (p.Arg319Cys) | SNV | Pathogenic |
| 208163 | c.740A>G (p.His247Arg) | SNV | Pathogenic |
| 265276 | c.956G>A (p.Arg319His) | SNV | Pathogenic |
| 279913 | c.1027C>T (p.Arg343Trp) | SNV | Pathogenic |
| 372540 | c.1727T>C (p.Ile576Thr) | SNV | Pathogenic |
| 650760 | c.952C>T (p.Arg318Cys) | SNV | Pathogenic |
| 208418 | c.1037C>G (p.Ala346Gly) | SNV | Pathogenic |
| 379608 | c.935G>A (p.Cys312Tyr) | SNV | Pathogenic |
| 6541 | c.1052A>G (p.Asp351Gly) | SNV | Pathogenic |
| 6548 | c.1009C>G (p.Arg337Gly) | SNV | Pathogenic |
| 544363 | c.1063G>A (p.Asp355Asn) | SNV | Pathogenic |
| 573933 | c.694A>G (p.Lys232Glu) | SNV | Pathogenic |
| 807713 | c.1790T>C (p.Ile597Thr) | SNV | Pathogenic |
| 1062831 | c.1050A>T (p.Arg350Ser) | SNV | Pathogenic |
| 650415 | c.1693T>G (p.Phe565Val) | SNV | Pathogenic |
| 544362 | c.1799G>A (p.Gly600Asp) | SNV | Pathogenic |
| 2579607 | c.1039T>C (p.Cys347Arg) | SNV | Pathogenic |
| 418520 | c.1040G>T (p.Cys347Phe) | SNV | Pathogenic |
| 2734605 | c.518G>A (p.Gly173Asp) | SNV | Pathogenic |
| 2734606 | c.932G>A (p.Ser311Asn) | SNV | Pathogenic |
| 1451179 | c.1695C>A (p.Phe565Leu) | SNV | Pathogenic |
| 3602195 | c.1654T>G (p.Phe552Val) | SNV | Pathogenic |
| 1018494 | c.796C>T (p.Arg266Ter) | SNV | Pathogenic |
| 1024583 | c.1861del (p.Ser621fs) | Deletion | Pathogenic |
| 194382 | c.1837_1841del (p.Pro613fs) | Deletion | Pathogenic |
| 576556 | c.1350-2A>G | SNV | Pathogenic |
| 3600613 | c.580-2A>G | SNV | Pathogenic |
| 30348 | c.797G>C (p.Arg266Pro) | SNV | Likely pathogenic |
| 372786 | c.605A>G (p.Tyr202Cys) | SNV | Likely pathogenic |
| 372787 | c.1048A>G (p.Arg350Gly) | SNV | Likely pathogenic |
| 373405 | c.1682G>A (p.Cys561Tyr) | SNV | Likely pathogenic |
| 381688 | c.1805T>C (p.Leu602Pro) | SNV | Likely pathogenic |
| 418521 | c.1922C>T (p.Ala641Val) | SNV | Likely pathogenic |
| 521882 | c.500C>T (p.Ser167Phe) | SNV | Likely pathogenic |
| 572273 | c.497C>A (p.Pro166His) | SNV | Likely pathogenic |
| 620399 | c.1927C>T (p.Arg643Ter) | SNV | Likely pathogenic |
| 651785 | c.935G>T (p.Cys312Phe) | SNV | Likely pathogenic |
| 653417 | c.738C>G (p.Asn246Lys) | SNV | Likely pathogenic |
| 846332 | c.1061C>A (p.Ala354Glu) | SNV | Likely pathogenic |
| 1178338 | c.3G>T (p.Met1Ile) | SNV | Likely pathogenic |
| 1299512 | c.881A>G (p.Gln294Arg) | SNV | Likely pathogenic |
| 1325219 | c.970_972del (p.Ile324del) | Deletion | Likely pathogenic |
| 1341520 | c.1789A>T (p.Ile597Phe) | SNV | Likely pathogenic |
| 1349518 | c.1973G>A (p.Trp658Ter) | SNV | Likely pathogenic |
| 1481716 | c.517G>A (p.Gly173Ser) | SNV | Likely pathogenic |
| 1486558 | c.797G>T (p.Arg266Leu) | SNV | Likely pathogenic |
| 1492561 | c.1769C>T (p.Pro590Leu) | SNV | Likely pathogenic |
| 1493391 | c.929G>A (p.Ser310Asn) | SNV | Likely pathogenic |
| 2019212 | c.731G>T (p.Cys244Phe) | SNV | Likely pathogenic |
| Variant | Effect | Delta Score |
|---|---|---|
| 3:189789839:TGAGG:T | donor_loss | 1.00 |
| 3:189789843:GTAA:G | donor_loss | 1.00 |
| 3:189864211:A:AG | acceptor_gain | 1.00 |
| 3:189864211:ACT:A | acceptor_gain | 1.00 |
| 3:189864211:ACTG:A | acceptor_gain | 1.00 |
| 3:189864213:T:A | acceptor_gain | 1.00 |
| 3:189864214:G:A | acceptor_gain | 1.00 |
| 3:189864227:A:G | acceptor_gain | 1.00 |
| 3:189789838:GTGAG:G | donor_gain | 0.99 |
| 3:189789844:T:G | donor_loss | 0.99 |
| 3:189808270:A:AG | acceptor_gain | 0.99 |
| 3:189808271:G:GG | acceptor_gain | 0.99 |
| 3:189808271:GCC:G | acceptor_gain | 0.99 |
| 3:189864220:A:AG | acceptor_gain | 0.99 |
| 3:189864221:A:G | acceptor_gain | 0.99 |
| 3:189834148:T:G | donor_gain | 0.99 |
| 3:189829119:T:A | acceptor_gain | 0.99 |
| 3:189864189:T:A | acceptor_gain | 0.99 |
| 3:189789840:GAG:G | donor_gain | 0.98 |
| 3:189808268:GCAGC:G | acceptor_loss | 0.98 |
| 3:189808269:CA:C | acceptor_loss | 0.98 |
| 3:189808270:A:C | acceptor_loss | 0.98 |
| 3:189808271:G:GC | acceptor_loss | 0.98 |
| 3:189808271:GC:G | acceptor_gain | 0.98 |
| 3:189808271:GCCA:G | acceptor_gain | 0.98 |
| 3:189810043:T:TA | acceptor_gain | 0.98 |
| 3:189864228:GCA:G | acceptor_gain | 0.98 |
| 3:189808271:GCCAC:G | acceptor_gain | 0.97 |
| 3:189829258:G:GT | donor_gain | 0.97 |
| 3:189829259:A:T | donor_gain | 0.97 |
| 3:189864226:A:AG | acceptor_gain | 0.99 |
| 3:189864228:G:GG | acceptor_gain | 0.96 |
| 3:189789843:G:GG | donor_gain | 0.96 |
| 3:189807194:TTTAG:T | donor_gain | 0.96 |
| 3:189808522:GGACG:G | donor_gain | 0.96 |
| 3:189808524:ACGGT:A | donor_loss | 0.96 |
| 3:189808525:CGGTA:C | donor_loss | 0.96 |
| 3:189808528:T:A | donor_loss | 0.96 |
| 3:189831430:A:AG | acceptor_loss | 0.96 |
| 3:189831434:GCAC:G | acceptor_loss | 0.96 |
| 3:189831435:CACAG:C | acceptor_loss | 0.96 |
| 3:189831436:ACAG:A | acceptor_loss | 0.96 |
| 3:189831437:CAGGT:C | acceptor_loss | 0.96 |
| 3:189831438:A:T | acceptor_loss | 0.96 |
| 3:189831439:GGTCA:G | acceptor_loss | 0.96 |
| 3:189833660:T:TA | donor_gain | 0.96 |
| 3:189833661:A:AA | donor_gain | 0.96 |
| 3:189808271:G:T | acceptor_gain | 0.95 |
| 3:189831427:T:G | acceptor_loss | 0.95 |
| 3:189808523:GACG:G | donor_gain | 0.95 |
| Variant | Protein Change | Score | Class |
|---|---|---|---|
| 3:189738722:T:A | I91N | 0.995 | likely_pathogenic |
| 3:189738722:T:C | I91T | 0.996 | likely_pathogenic |
| 3:189738722:T:G | I91S | 0.996 | likely_pathogenic |
| 3:189738716:T:A | I89N | 0.983 | likely_pathogenic |
| 3:189738716:T:G | I89S | 0.980 | likely_pathogenic |
| 3:189738671:T:C | L74S | 0.978 | likely_pathogenic |
| 3:189738728:T:A | M93K | 0.971 | likely_pathogenic |
| 3:189738728:T:G | M93R | 0.969 | likely_pathogenic |
| 3:189738676:T:C | F76L | 0.953 | likely_pathogenic |
| 3:189738677:T:C | F76S | 0.942 | likely_pathogenic |
| 3:189737850:T:A | I58N | 0.940 | likely_pathogenic |
| 3:189738729:G:A | M93I | 0.932 | likely_pathogenic |
| 3:189738728:T:C | M93T | 0.930 | likely_pathogenic |
| 3:189738731:A:T | D94V | 0.921 | likely_pathogenic |
| 3:189808278:T:G | Y111D | 0.918 | likely_pathogenic |
| 3:189738716:T:C | I89T | 0.912 | likely_pathogenic |
| 3:189738730:G:T | D94Y | 0.908 | likely_pathogenic |
| 3:189737862:T:C | L62P | 0.906 | likely_pathogenic |
| 3:189808286:C:A | N113K | 0.898 | likely_pathogenic |
| 3:189738677:T:G | F76C | 0.885 | likely_pathogenic |
| 3:189808278:T:C | Y111H | 0.882 | likely_pathogenic |
| 3:189737850:T:G | I58S | 0.877 | likely_pathogenic |
| 3:189738730:G:C | D94H | 0.867 | likely_pathogenic |
| 3:189738743:T:C | M98T | 0.865 | likely_pathogenic |
| 3:189738665:T:G | I72S | 0.860 | likely_pathogenic |
| 3:189808282:C:A | T112K | 0.855 | likely_pathogenic |
| 3:189738710:A:T | N87I | 0.851 | likely_pathogenic |
| 3:189737852:T:A | W59R | 0.846 | likely_pathogenic |
| 3:189738737:T:A | I96N | 0.846 | likely_pathogenic |
| 3:189738737:T:G | I96S | 0.844 | likely_pathogenic |
| 3:189808279:A:C | Y111S | 0.840 | likely_pathogenic |
| 3:189738737:T:C | I96T | 0.832 | likely_pathogenic |
| 3:189737862:T:G | L62R | 0.826 | likely_pathogenic |
| 3:189738724:A:C | S92R | 0.819 | likely_pathogenic |
| 3:189737850:T:C | I58T | 0.813 | likely_pathogenic |
| 3:189738743:T:A | M98K | 0.812 | likely_pathogenic |
| 3:189738743:T:G | M98R | 0.813 | likely_pathogenic |
| 3:189738662:C:T | P71L | 0.812 | likely_pathogenic |
| 3:189738731:A:C | D94A | 0.806 | likely_pathogenic |
| 3:189737841:T:C | F55S | 0.806 | likely_pathogenic |
| 3:189808282:C:G | T112R | 0.775 | likely_pathogenic |
| 3:189738731:A:G | D94G | 0.771 | likely_pathogenic |
| 3:189738740:G:C | R97P | 0.766 | likely_pathogenic |
| 3:189808278:T:A | Y111N | 0.763 | likely_pathogenic |
| 3:189738721:A:T | I91F | 0.761 | likely_pathogenic |
| 3:189737862:T:A | L62Q | 0.760 | likely_pathogenic |
| 3:189738671:T:G | L74W | 0.759 | likely_pathogenic |
| 3:189808285:A:T | N113I | 0.743 | likely_pathogenic |
| 3:189808279:A:G | Y111C | 0.742 | likely_pathogenic |
| 3:189737797:G:A | M40I | 0.741 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology Pathway Membership (Reactome) Total pathway count: 11
| Pathway ID | Pathway Name |
|---|---|
| R-HSA-139915 | Activation of PUMA and translocation to mitochondria |
| R-HSA-5620971 | Pyroptosis |
| R-HSA-5628897 | TP53 Regulates Metabolic Genes |
| R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release |
| R-HSA-6803205 | TP53 regulates transcription of additional cell death genes |
| R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases |
| R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands |
| R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors |
| R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis |
| R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells |
| R-HSA-9938206 | Developmental Lineage of Mammary Stem Cells |
| GO ID | Term |
|---|---|
| GO:0000122 | negative regulation of transcription by RNA polymerase II |
| GO:0001501 | skeletal system development |
| GO:0001736 | establishment of planar polarity |
| GO:0002064 | epithelial cell development |
| GO:0006338 | chromatin remodeling |
| GO:0006366 | transcription by RNA polymerase II |
| GO:0006915 | apoptotic process |
| GO:0006974 | DNA damage response |
| GO:0007219 | Notch signaling pathway |
| GO:0007283 | spermatogenesis |
| GO:0007499 | ectoderm and mesoderm interaction |
| GO:0008340 | determination of adult lifespan |
| GO:0009954 | proximal/distal pattern formation |
| GO:0010481 | epidermal cell division |
| GO:0010482 | regulation of epidermal cell division |
| GO:0010838 | positive regulation of keratinocyte proliferation |
| GO:0030216 | keratinocyte differentiation |
| GO:0030859 | polarized epithelial cell differentiation |
| GO:0031069 | hair follicle morphogenesis |
| GO:0033147 | negative regulation of intracellular estrogen receptor signaling |
| GO ID | Term |
|---|---|
| GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO:0002039 | p53 binding |
| GO:0003677 | DNA binding |
| GO:0003682 | chromatin binding |
| GO:0003684 | damaged DNA binding |
| GO:0003700 | DNA-binding transcription factor activity |
| GO:0042802 | identical protein binding |
| GO:0046872 | metal ion binding |
| GO:0050699 | WW domain binding |
| GO:0097371 | MDM2/MDM4 family protein binding |
| GO:1990841 | promoter-specific chromatin binding |
| GO ID | Term |
|---|---|
| GO:0000785 | chromatin |
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0005737 | cytoplasm |
| GO:0030425 | dendrite |
| GO:0032991 | protein-containing complex |
Section 8: Protein Interactions & Molecular Networks Protein-Protein Interactions STRING Interactions Total interaction count: 2,404 TOP 50 Highest-Confidence Interacting Proteins
| UniProt | Gene | Score |
|---|---|---|
| P48431 | TP73 | 918 |
| O15350 | TP73 | 779 |
| O00744 | IL9 | 760 |
| P56179 | KRT86 | 723 |
| Q96FX8 | DGCR14 | 716 |
| P02533 | KRT14 | 704 |
| P42336 | PIK3CA | 674 |
| P01106 | MYC | 673 |
| P13647 | KRT5 | 653 |
| P56178 | KRT79 | 649 |
| Q86XZ4 | KRT78 | 649 |
| P42771 | CDKN2A | 648 |
| Q9NRW4 | IRF4 | 616 |
| Q00987 | MDM2 | 599 |
| O14686 | KMT2D | 594 |
| P46937 | YAP1 | 587 |
| Q9H0Z9 | HACE1 | 579 |
| P11684 | SCGB1A1 | 578 |
| Q96D03 | DDIT4L | 547 |
| P55317 | HNF3A | 532 |
| O14896 | IRF6 | 525 |
| O60479 | DYRK1A | 522 |
| Q04206 | RELA | 516 |
| P43699 | NKX2-1 | 514 |
| P05412 | JUN | 513 |
| Q9HC84 | MUC5B | 507 |
| P00533 | EGFR | 497 |
| P78504 | JAG1 | 493 |
| P46531 | NOTCH1 | 490 |
| P78337 | PITX1 | 490 |
| Q9Y6A5 | TACC3 | 489 |
| O96017 | CHEK2 | 485 |
| P17676 | CEBPB | 482 |
| Q32MQ0 | CDC27 | 480 |
| Q96KA5 | CLPX | 476 |
| P18075 | BMP7 | 469 |
| Q9UM73 | ALK | 461 |
| Q14209 | E2F2 | 455 |
| Q9H161 | RAPGEF6 | 454 |
| P04626 | ERBB2 | 453 |
| Q9H2X6 | HIPK2 | 450 |
| A6NLE4 | TUBB4B | 447 |
| Q92949 | FOXJ1 | 446 |
| P29034 | S100A2 | 445 |
| P78360 | GRHL2 | 445 |
| P56279 | KRT85 | 444 |
| P60484 | PTEN | 444 |
| Q14517 | FAT1 | 444 |
| Q01954 | BRPF1 | 443 |
| Partner Gene | Type | Score |
|---|---|---|
| TP63 (self) | direct interaction | 0.77 |
| TP73 | direct interaction | 0.77 |
| TP53 | physical association | 0.59 |
| YAP1 | direct interaction | 0.61 |
| SMAD2 | physical association | 0.59/0.67 |
| HNRNPAB | physical association | 0.57 |
| PPP1R13B | direct interaction | 0.54 |
| NIPSNAP3A | physical association | 0.51 |
| SATB2 | physical association/colocalization | 0.46 |
| NEDD4 | direct interaction | 0.44 |
| PPP1R13L | direct interaction | 0.44 |
| TP53BP2 | direct interaction | 0.44 |
| HIPK2 | phosphorylation reaction | 0.44 |
| UniProt | Top Similarity | Avg Similarity |
|---|---|---|
| O88898 (Mouse Trp63) | 1.0000 | 0.9883 |
| Q9JJP6 (Mouse Tp63) | 1.0000 | 0.9883 |
| Q9NZN8 (TP73) | 1.0000 | 0.9854 |
| Q86U70 (CDH26) | 1.0000 | 0.9822 |
| P70662 | 1.0000 | 0.9823 |
| Q8C5L3 | 1.0000 | 0.9854 |
| O15350 (TP73) | 0.9999 | 0.9879 |
| Q9ES03 | 0.9999 | 0.9904 |
| Q9XSK8 | 0.9999 | 0.9878 |
| Q9UMR3 | 0.9999 | 0.9901 |
| O42252 | 0.9998 | 0.9816 |
| Q8AXW8 | 0.9998 | 0.9905 |
| Q3SA46 | 0.9998 | 0.9906 |
| Q9W679 | 0.9978 | 0.9918 |
| P26323 | 0.9997 | 0.9853 |
| Q01543 | 0.9997 | 0.9849 |
| Q29RS8 | 0.9997 | 0.9848 |
| Q9JJP2 | 0.9996 | 0.9878 |
| Q8UW76 | 0.9996 | 0.9906 |
| Q90837 | 0.9995 | 0.9873 |
| UniProt | Identity | BitScore |
|---|---|---|
| P56423 | 100% | 773 |
| P56424 | 100% | 773 |
| P61260 | 100% | 773 |
| P67938 | 100% | 748 |
| P67939 | 100% | 748 |
| O88898 (Mouse Trp63) | 99.6% | 1330 |
| Q9JJP6 (Mouse Tp63) | 99.6% | 1333 |
| O57538 | 99.4% | 641 |
| Q92143 | 99.4% | 641 |
| P13481 | 99.0% | 769 |
| O36006 | 97.8% | 654 |
| Q64662 | 97.8% | 604 |
| O15350 (TP73) | 97.5% | 1242 |
| Q9XSK8 (TP73) | 97.5% | 1243 |
| P04637 (TP53) | 95.4% | 736 |
| P79892 | 94.6% | 444 |
| Q29480 | 94.6% | 353 |
| Q9TTA1 | 93.1% | 709 |
| O09185 | 91.2% | 707 |
| Q00366 | 91.2% | 715 |
Section 9: Transcription Factor Regulatory Data TP63 as a Transcription Factor DNA Binding Motifs (JASPAR)
| Motif ID | Name | Collection | Class | Family |
|---|---|---|---|---|
| MA0525.1 | TP63 | CORE | p53 domain factors | p53-related factors |
| MA0525.2 | TP63 | CORE | p53 domain factors | p53-related factors |
| Target Gene | Regulation | Confidence |
|---|---|---|
| CDKN1A | Activation | High |
| CDKN2A | Repression | High |
| BAX | Activation | High |
| BBC3 (PUMA) | Unknown | High |
| FAS | Activation | High |
| EGFR | Repression | High |
| EPHA2 | Repression | High |
| FASN | Repression | High |
| CDC25A | Repression | High |
| CDK1 | Activation | High |
| CKS1B | Activation | High |
| CKS2 | Activation | High |
| DLX6 | Activation | High |
| APOD | Activation | High |
| AQP3 | Activation | Low |
| CCDC3 | Activation | - |
| ABCB1 | - | High |
| ADA | - | High |
| AHR | - | High |
| ALOX12 | - | High |
| AR | - | High |
| ATM | - | High |
| AXL | - | High |
| B4GALT1 | - | High |
| BRCA1 | Unknown | - |
| CASP1 | - | High |
| CCND3 | - | High |
| CD44 | - | High |
| CDC25C | - | High |
| CDH1 | - | High |
| CHUK | - | High |
| CLDN1 | - | High |
| CLDN20 | - | High |
| CRABP1 | - | High |
| CSF1 | - | High |
| CSF2 | - | High |
| CTNNB1 | - | High |
| DDR1 | - | High |
| DHRS3 | - | High |
| DLX5 | - | High |
| ERBB2 | - | High |
| FDXR | Unknown | High |
| FGFR3 | - | High |
| CDKN1C | Unknown | High |
| BMAL1 | - | High |
| CHN1 | - | High |
| AACS | - | High |
| AHCYL1 | - | High |
| CCDC28A | - | High |
| FBXO32 | - | High |
| TF | Regulation | Confidence |
|---|---|---|
| TP53 | Repression | High |
| STAT3 | Activation | High |
| RELA/NFKB | - | High |
| JUN | - | High |
| AR | - | High |
| ESR2 | - | High |
| TBP | - | High |
| SOX2 | Activation | - |
| SATB2 | Repression | - |
| CEBPA | Activation | Low |
| BHLHE40 | - | High |
| BRCA1 | Unknown | - |
| CTNNB1 | - | - |
Section 10: Drug & Pharmacology Data PharmGKB Gene Information
| Property | Value |
|---|---|
| PharmGKB ID | PA162406776 |
| VIP Gene | Yes (Very Important Pharmacogene) |
| Symbol | TP63 |
Cancer biology and tumor suppression
Ectodermal development disorders
Potential indirect targeting through:
Upstream signaling pathways
Protein-protein interaction modulators
Transcriptional regulation Clinical Trials No direct clinical trials targeting TP63 protein found. Related trials involve:
Diseases caused by TP63 mutations (ectodermal dysplasias)
Cancer studies where TP63 expression is a biomarker Pharmacogenomics No established drug-gene interactions affecting drug response currently documented for TP63.
Section 11: Expression Profiles Tissue Expression (Bgee)
| Property | Value |
|---|---|
| Expression breadth | Ubiquitous |
| Total present calls | 207 |
| Total absent calls | 76 |
| Total conditions | 283 |
| Max expression score | 98.64 |
| Average expression score | 63.76 |
| Gold quality count | 255 |
| Tissue (UBERON) | Expression Score | Quality |
|---|---|---|
| upper leg skin (UBERON:0004262) | 98.64 | gold |
| skin of hip (UBERON:0001554) | 98.26 | gold |
| upper arm skin (UBERON:0004263) | 98.06 | gold |
| penis (UBERON:0000989) | 98.00 | gold |
| hair follicle (UBERON:0002073) | 97.57 | gold |
| mammalian vulva (UBERON:0000997) | 97.53 | gold |
| gingiva (UBERON:0001828) | 97.36 | gold |
| nipple (UBERON:0002030) | 97.32 | gold |
| tongue squamous epithelium (UBERON:0006919) | 97.08 | gold |
| skin of abdomen (UBERON:0001416) | 97.00 | gold |
| gingival epithelium (UBERON:0001949) | 96.98 | gold |
| zone of skin (UBERON:0000014) | 96.53 | gold |
| pharyngeal mucosa (UBERON:0000355) | 96.17 | gold |
| skin of leg (UBERON:0001511) | 95.93 | gold |
| oral cavity (UBERON:0000167) | 95.66 | gold |
| cervix epithelium (UBERON:0004801) | 95.43 | gold |
| esophagus mucosa (UBERON:0002469) | 94.71 | gold |
| squamous epithelium (UBERON:0006914) | 94.57 | gold |
| esophagus squamous epithelium (UBERON:0006920) | 93.81 | gold |
| body of tongue (UBERON:0011876) | 93.78 | gold |
| rectus abdominis muscle (UBERON:0004511) | 93.65 | gold |
| epithelium of esophagus (UBERON:0001976) | 92.89 | gold |
| cervix squamous epithelium (UBERON:0006922) | 91.75 | gold |
| deltoid muscle (UBERON:0001476) | 91.51 | gold |
| epithelium of nasopharynx (UBERON:0001951) | 91.45 | gold |
| tibialis anterior (UBERON:0001385) | 91.21 | gold |
| gluteal muscle (UBERON:0002000) | 91.21 | gold |
| lower esophagus mucosa (UBERON:0035834) | 91.15 | gold |
| olfactory nasal mucosa (UBERON:0005386) | 91.14 | gold |
| tongue (UBERON:0001723) | 90.87 | gold |
| Experiment ID | Description | Cells |
|---|---|---|
| E-ANND-2 | GTEx snRNAseq atlas | 209,126 |
| E-CURD-114 | Human airway epithelium (smoking effects) | 81,801 |
| E-CURD-7 | Adult human breast epithelial cells | 867 |
| E-ENAD-21 | Human breast epithelial cells | 867 |
| E-GEOD-86618 | Lung epithelial cells (control vs IPF) | 540 |
| E-MTAB-10596 | Human dental follicle organoids | 3,388 |
- High expression in basal epithelial cells
- Expression in keratinocyte populations
- Present in mammary epithelial progenitors
- Expressed in airway basal cells
Section 12: Disease Associations Mendelian/Monogenic Disease Links (GenCC) Total disease associations: 16
| Disease | Disease ID | Evidence | Inheritance |
|---|---|---|---|
| EEC syndrome 3 | OMIM:604292 | Definitive | AD |
| Ankyloblepharon-ectodermal defects-cleft lip/palate | OMIM:106260 | Definitive | AD |
| Rapp-Hodgkin syndrome | OMIM:129400 | Definitive | AD |
| ADULT syndrome | OMIM:103285 | Definitive | AD |
| Limb-mammary syndrome | OMIM:603543 | Definitive | AD |
| Split hand-foot malformation 4 | MONDO:0011535 | Moderate | AD |
| Premature ovarian failure 21 | OMIM:620311 | Strong | AD |
| TP63-related ectodermal dysplasia spectrum | MONDO:1040001 | Strong | AD |
| Orphanet ID | Disease Name | Type | Phenotype Count |
|---|---|---|---|
| 1896 | EEC syndrome | Malformation syndrome | 61 |
| 69085 | Limb-mammary syndrome | Malformation syndrome | 32 |
| 978 | ADULT syndrome | Malformation syndrome | 24 |
| 2440 | Split hand-split foot malformation | Malformation syndrome | 8 |
| 199306 | Cleft lip/palate | Morphological anomaly | 21 |
| 199302 | Isolated cleft lip | Morphological anomaly | 19 |
| 93930 | Classic bladder exstrophy | Clinical subtype | 13 |
| 141291 | Cleft lip and alveolus | Morphological anomaly | 12 |
| 1072 | Ankyloblepharon filiforme adnatum-cleft palate | Clinical subtype | 5 |
| HPO ID | Phenotype |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000968 | Ectodermal dysplasia |
| HP:0000175 | Cleft palate |
| HP:0000204 | Cleft upper lip |
| HP:0000202 | Orofacial cleft |
| HP:0000668 | Hypodontia |
| HP:0000677 | Oligodontia |
| HP:0000682 | Abnormal dental enamel |
| HP:0000958 | Dry skin |
| HP:0000962 | Hyperkeratosis |
| HP:0000966 | Hypohidrosis |
| HP:0000970 | Anhidrosis |
| HP:0000982 | Palmoplantar keratoderma |
| HP:0000522 | Alacrima |
| HP:0000564 | Lacrimal duct atresia |
| HP:0000579 | Nasolacrimal duct obstruction |
| HP:0000653 | Sparse eyelashes |
| HP:0000561 | Absent eyelashes |
| HP:0000365 | Hearing impairment |
| HP:0000405 | Conductive hearing impairment |
| HP:0000403 | Recurrent otitis media |
| HP:0000104 | Renal agenesis |
| HP:0000110 | Renal dysplasia |
| HP:0000126 | Hydronephrosis |
| HP:0000047 | Hypospadias |
| HP:0000028 | Cryptorchidism |
| HP:0000054 | Micropenis |
| HP:0000151 | Aplasia of the uterus |
| HP:0000786 | Primary amenorrhea |
| HP:0000778 | Hypoplasia of the thymus |
| HP:0000272 | Malar flattening |
| HP:0000327 | Hypoplasia of the maxilla |
| HP:0000431 | Wide nasal bridge |
| HP:0000453 | Choanal atresia |
| HP:0000491 | Keratitis |
| HP:0000498 | Blepharitis |
| HP:0000509 | Conjunctivitis |
| HP:0000613 | Photophobia |
| HP:0000621 | Entropion |
| HP:0000708 | Atypical behavior |
| HP:0000750 | Delayed speech and language development |
| HP:0001511 | Intrauterine growth retardation |
| HP:0001999 | Abnormal facial shape |
| HP:0002007 | Frontal bossing |
| HP:0002164 | Nail dysplasia |
| HP:0008404 | Nail dystrophy |
| HP:0008388 | Abnormal toenail morphology |
| HP:0001817 | Absent fingernail |
| HP:0001798 | Anonychia |
| HP:0001792 | Small nail |
| Study ID | Trait/Disease | P-value |
|---|---|---|
| GCST001140 | Lung cancer | 7×10⁻²⁶ |
| GCST008834 | Non-small cell lung cancer | 1×10⁻²⁰ |
| GCST001609 | Lung adenocarcinoma | 7×10⁻¹⁷ |
| GCST010148 | Cutaneous squamous cell carcinoma | 6×10⁻¹⁵ |
| GCST003605 | EGFR mutation-positive lung adenocarcinoma | 9×10⁻¹³ |
| GCST000810 | Lung adenocarcinoma | 7×10⁻¹² |
| GCST004744 | Lung adenocarcinoma | 7×10⁻¹² |
| GCST003327 | Squamous cell carcinoma | 1×10⁻¹¹ |
| GCST002240 | Bladder cancer | 2×10⁻¹¹ |
| GCST000842 | Bladder cancer | 2×10⁻¹⁰ |
| GCST011456 | Serum CC16 levels | 5×10⁻¹⁰ |
| GCST002466 | Lung cancer | 7×10⁻¹⁰ |
| GCST001740 | Lung cancer | 4×10⁻⁹ |
| GCST001320 | Acute lymphoblastic leukemia (childhood) | 3×10⁻⁸ |
| GCST002874 | Psoriasis | 4×10⁻⁸ |
| GCST005434 | Pancreatic cancer | 5×10⁻⁸ |
| GCST002991 | Pancreatic cancer | 2×10⁻⁸ |
| GCST005752 | Systemic lupus erythematosus | 2×10⁻⁶ |
| GCST009391 | Metabolite levels | 9×10⁻⁶ |
| GCST003268 | Psoriasis vulgaris | 3×10⁻⁶ |
- Strong associations with lung cancer (multiple studies, highly significant)
- Associations with bladder cancer
- Links to squamous cell carcinomas (skin, lung)
- Association with childhood ALL
- Psoriasis susceptibility
SUMMARY STATISTICS
| Category | Count |
|---|---|
| Gene identifiers | 4 primary databases |
| Ensembl transcripts | 14 (12 protein-coding) |
| RefSeq transcripts | 13 reviewed human |
| CCDS entries | 10 |
| UniProt entries | 5 (1 reviewed) |
| Exons (canonical) | 14 |
| PDB structures | 25 |
| InterPro domains | 10 |
| Orthologs | 4 model organisms |
| ClinVar variants | 827 total |
| Pathogenic variants | 66 |
| Likely pathogenic | 50 |
| SpliceAI predictions | 2,303 |
| AlphaMissense predictions | 4,516 |
| Reactome pathways | 11 |
| GO annotations | 72 |
| STRING interactions | 2,404 |
| IntAct interactions | 88 |
| TF target genes | 246+ |
| JASPAR motifs | 2 |
| Disease associations | 16 (GenCC) |
| HPO phenotypes | 254 |
| GWAS associations | 31 |
| Expression conditions | 283 (207 present) |
| Single-cell datasets | 6 |
╔══════════════════════════════════════════════════════════════════════════════╗ ║ END OF TP63 REFERENCE ║ ║ Generated via BioBTree Database Queries ║ ╚══════════════════════════════════════════════════════════════════════════════╝ I’ve compiled a comprehensive cross-database identifier and functional mapping reference for human TP63 (tumor protein p63). Key Highlights TP63 is a critical transcription factor in the p53 family with:
Gene location: Chromosome 3q28 (189,631,389-189,897,276, + strand)
14 transcripts (12 protein-coding), with NM_003722.5 as MANE Select
680 amino acid canonical protein (Q9H3D4)
25 experimental structures in PDB
827 clinical variants (66 pathogenic, 50 likely pathogenic)
2,404 protein interactions (STRING)
246+ transcriptional targets as a transcription factor Major disease associations:
EEC syndrome (ectrodactyly-ectodermal dysplasia-clefting)
ADULT syndrome
Limb-mammary syndrome
Rapp-Hodgkin syndrome
Strong GWAS links to lung cancer, bladder cancer, and squamous cell carcinomas Expression pattern: Highly expressed in stratified epithelia (skin, oral mucosa, esophagus, cervix), consistent with its essential role in epithelial development and maintenance.